Status: current, Primitive. Date: 30-Nov 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3013271000168111 | Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3013281000168114 | Orencia 125 mg/mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has unit of use | syringe | true | Inferred relationship | Some | 1712235925 | |
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | Orencia | true | Inferred relationship | Some | ||
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Is a | abatacept 125 mg/mL injection, syringe | true | Inferred relationship | Some | ||
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has Australian BoSS | abatacept | true | Inferred relationship | Some | 1712235924 | |
| Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | has intended active ingredient | abatacept | true | Inferred relationship | Some | 1712235924 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Orencia 125 mg/mL injection, 4 x 1 mL syringes | has TPUU | True | Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Orencia 125 mg/mL injection, 4 x 1 mL syringes | has TPUU | True | Orencia (abatacept 125 mg / 1 mL) injection, 1 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR